A £4 million investment fund, backed by University College London, will help scientists exploit the human genome.
The Bloomsbury BioSeed Fund has been formed by a six-strong consortium of biomedical research centres including University College London, the Cancer Research Campaign, Imperial Cancer Research Fund, Institute of Cancer Research, London School of Pharmacy and the Royal Veterinary College.